TrialLeukemia2014
The prognostic relevance of flt3 and npm1 mutations on older patients treated intensively or non-intensively: a study of 1312 patients in the UK NCRI AML16 trial.
M Lazenby et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this paperpooled ittrialcites it